Tuesday, February 5, 2013- January Top 10: Keryxat Motley Fool (Tue, Feb 5)
- KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Feb 5)
- Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Kerx Biopharmaceuticals, Inc.PR Newswire (Tue, Feb 5)
- Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Tue, Feb 5)
- Ziopharm's Sarcoma Study And The Feuerstein-Ratain Ruleat TheStreet (Tue, Feb 5)
Monday, February 4, 2013- 3 Stocks Laboring to Surviveat Motley Fool (Mon, Feb 4)
- Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX)Marketwired (Mon, Feb 4)
- A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcementat Seeking Alpha (Mon, Feb 4)
- Tyson Foods Named Top Pick and 4 Stock Analyses Turning Headsat Wall St. Cheat Sheet (Mon, Feb 4)
- Keryx Falls On Questions About Zerenex Market Exclusivityat TheStreet (Mon, Feb 4)
- Research Report Misses The Mark - A Second Chance To Own Keryxat Seeking Alpha (Mon, Feb 4)
- Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Mon, Feb 4)
- Keryx slide attributable to Zerenex market exclusivity worries, The Street saystheflyonthewall.com (Mon, Feb 4)
- This Week in Biotechat Motley Fool (Mon, Feb 4)
- Keryx Biopharmaceuticals: Time To Get Shortat Seeking Alpha (Mon, Feb 4)
Friday, February 1, 2013 Thursday, January 31, 2013Add KERX News to My Yahoo!   | |
|
0.00 (0.02%) May 24, 4:35PM EDT